We are live on ! Find out more
MBOT icon

Microbot Medical

38 hedge funds and large institutions have $1.24M invested in Microbot Medical in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,300% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 1

52% more funds holding

Funds holding: 2538 (+13)

32% more capital invested

Capital invested by funds: $933K → $1.24M (+$302K)

0.19% more ownership

Funds ownership: 6.33%6.52% (+0.19%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
38
Holders Change
+13
Holders Change %
+52%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
6
Reduced
7
Closed
1
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$2K

MBOT Hedge Fund Activity: Q4 2024 in Review

38 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2024, worth a combined $1.24M — up 32% from $933K a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MBOT positions and 1 closed out — a net gain of 13 holders — while 6 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $103K. The largest seller was AlphaCentric Advisors, cutting an estimated $58.7K.

  • 38 institutional investors held Microbot Medical (MBOT) as of Q4 2024, up from 25 in Q3 2024.
  • Funds reported $1.24M of Microbot Medical stock for Q4 2024, up 32% quarter-over-quarter.
  • 14 funds opened new Microbot Medical positions in Q4 2024 and 1 closed out, a net change of +13 holders.
  • The largest Microbot Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $103K added.
  • The largest Microbot Medical seller in Q4 2024 was AlphaCentric Advisors, an estimated $58.7K sold.

Based on aggregated 13F filings for Q4 2024.